← All dividend history charts · Own MRNY? See how much it's paid you back →
- Pays: weekly — typically going ex-dividend on Thursdays (monthly during its first year).
- First paid: December 2023.
- What it is: the YieldMax fund pointed at MODERNA — a biotech whose stock has swung with vaccine cycles, pipeline news, and boom-bust sentiment.
- The stunning 2024: about $94 per share distributed — against a fund priced near $15.60 today.
- Today's pace: roughly 37-43 cents a week — still a towering rate on a shrunken base, and far below the 2024 firehose.
MRNY makes no promise to pay any particular amount; each payout depends on option income earned on Moderna's volatility, and the fund's price history includes that entire ride.
MRNY pays weekly (monthly during 2024). Each point below is one distribution since December 2023 — the 2024 bars dwarf everything after.
Loading the latest data…
Each point is one payment; the line ends at the most recent payout. The table below totals them by year.
- Trailing 12 months: $15.88 per share across 49 payments — down 41% from $26.70 in the 12 months before (split-adjusted, in today's share terms). What a change like that does to your income →
- Current pace: recent payments annualize to $12.71 — 20% below the trailing figure. When those two disagree, the trailing yield is quoting the past. Live cut & raise board →
- Share price, same 12 months: up 85% (dividends excluded) — income and principal are one story. Erosion Index →
- Record: 71 payments over 3 years; the largest single payment was $26.54 (Jan 2024), split-adjusted.
- Payment drops ≥20% below trend, last 24 months: 31. Get alerted to the next one →
- Payment steadiness: the last 12 checks wobble ±47% around their median. Compare that against any fund →
Every figure above is computed from MRNY's actual payment record and share-price history as of the date shown — not copied from a fact sheet. Recomputed regularly; the chart above always shows the live data.
Writing about MRNY? Drop this live card into your blog, newsletter, or forum post. It redraws itself with fresh payment data on every view — no stale screenshots. Free to use with the link included.
Click the code to select it, then copy. Updates hourly. All 169 tickers, iframe & Markdown versions →
| Recent Ex-Dividend Dates | Distribution / Share |
|---|
"Next expected" is estimated from MRNY's recent payment rhythm — the fund announces exact dates shortly before each payout, and the data feed can lag a few days. You must own shares before the ex-dividend date to receive that payout; the cash typically arrives days later. See every fund's upcoming date on the live dividend calendar.
A real total-return estimate, assuming every payout was reinvested — including what happened to the share price. Before taxes and fees. Past performance does not predict the future.
Moderna's stock doesn't drift — it gaps, on trial results, guidance cuts, and pandemic echoes. That gap-risk makes its options extraordinarily expensive, which is why MRNY's 2024 payout total (~$94 a share) reads like fiction. The same gap-risk is why the fund's price carries deep scars: option-income funds keep their underlying's downside, and Moderna's downside came in elevator drops, not stairs.
Today's checks — around 40 cents weekly — remain huge relative to the fund's small price, and the trailing yield tops most tables. Treat that as a volatility reading, not an income promise, and let the total-return backtest above deliver the verdict on what holders actually experienced.
| Year | Total Distributions / Share | Payments | Change vs Prior Year |
|---|
Data source: Yahoo Finance. Figures are per share; the current year may be partial and figures should be verified against official sources.
Calculated from complete calendar years in the data above. Past results don't guarantee future payments.
When Is MRNY's Next Ex-Dividend Date?
MRNY pays weekly — typically going ex-dividend on Thursdays. The exact date of each payout is announced by the fund only shortly beforehand, so no site can promise the next date — but the live schedule box above shows the most recent ex-dividend date and the expected window for the next one, computed from MRNY's actual payment rhythm. Remember: you must own shares before the ex-dividend date to receive that payout.
MRNY's Record: The Firehose and the Fade
MRNY — the YieldMax MRNA Option Income Strategy ETF — began paying in December 2023 and delivered one of the most extreme first years in the family's history: roughly $94 per share across 2024. Then Moderna's post-pandemic drama cooled, and 2025 brought about $21.47, with 2026 running near 40 cents a week. Every step of that staircase is on the chart above.
Why Biotech Premiums Boom and Bust
Options on Moderna price in events — trial readouts, guidance, regulatory decisions — that can gap the stock 20% overnight. Sellers of those options collect accordingly, and MRNY passed the harvest through. But event-driven stocks also deliver their losses all at once, and an option-income fund absorbs each gap down in full. The result: a payout record that looks like a lottery win and a price record that explains its cost.
Where MRNY Fits
For nearly everyone, as a chart to learn from rather than a fund to hold. For the specific investor with a view on Moderna's volatility staying rich, it's the direct harvest. Either way, size any position from the current pace on the live calendar, and read the family guide first.
Understand These Funds Before You Buy
Option income, return of capital, NAV erosion — the three things every YieldMax buyer should understand.
Read: What Are YieldMax ETFs?